Grantham, Mayo, Van Otterloo & Co (GMO)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3M | Sell |
65,283
-18,047
| -22% | -$9.47M | 0.1% | 105 |
|
|
2025
Q1 | $52.9M | Buy |
83,330
+20,351
| +32% | +$12.9M | 0.17% | 63 |
|
|
2024
Q4 | $44.9M | Buy |
62,979
+10,982
| +21% | +$7.82M | 0.15% | 82 |
|
|
2024
Q3 | $54.7M | Sell |
51,997
-5,267
| -9% | -$5.54M | 0.17% | 71 |
|
|
2024
Q2 | $60.2M | Sell |
57,264
-596
| -1% | -$626K | 0.2% | 61 |
|
|
2024
Q1 | $55.7M | Sell |
57,860
-9,240
| -14% | -$8.89M | 0.2% | 69 |
|
|
2023
Q4 | $58.9M | Buy |
67,100
+9,160
| +16% | +$8.05M | 0.26% | 63 |
|
|
2023
Q3 | $47.7M | Buy |
57,940
+5,036
| +10% | +$4.14M | 0.23% | 77 |
|
|
2023
Q2 | $38M | Sell |
52,904
-14,238
| -21% | -$10.2M | 0.18% | 105 |
|
|
2023
Q1 | $55.2M | Sell |
67,142
-4,000
| -6% | -$3.29M | 0.28% | 66 |
|
|
2022
Q4 | $51.3M | Buy |
71,142
+17,142
| +32% | +$12.4M | 0.27% | 68 |
|
|
2022
Q3 | $37.2M | Sell |
54,000
-2,400
| -4% | -$1.65M | 0.21% | 85 |
|
|
2022
Q2 | $33.3M | Buy |
56,400
+8,500
| +18% | +$5.02M | 0.18% | 105 |
|
|
2022
Q1 | $33.5M | Buy |
47,900
+500
| +1% | +$349K | 0.16% | 106 |
|
|
2021
Q4 | $29.9M | Sell |
47,400
-1,900
| -4% | -$1.2M | 0.14% | 121 |
|
|
2021
Q3 | $29.8M | Buy |
49,300
+800
| +2% | +$484K | 0.15% | 115 |
|
|
2021
Q2 | $27.1M | Buy |
48,500
+6,900
| +17% | +$3.85M | 0.14% | 131 |
|
|
2021
Q1 | $19.7M | Buy |
41,600
+13,444
| +48% | +$6.36M | 0.11% | 151 |
|
|
2020
Q4 | $13.6M | Buy |
28,156
+27,700
| +6,075% | +$13.4M | 0.08% | 167 |
|
|
2020
Q3 | $255K | Hold |
456
| – | – | ﹤0.01% | 715 |
|
|
2020
Q2 | $284K | Buy |
+456
| New | +$284K | ﹤0.01% | 677 |
|
|
2019
Q3 | – | Sell |
-11,100
| Closed | -$3.47M | – | 778 |
|
|
2019
Q2 | $3.47M | Buy |
11,100
+10,600
| +2,120% | +$3.32M | 0.02% | 357 |
|
|
2019
Q1 | $205K | Buy |
+500
| New | +$205K | ﹤0.01% | 678 |
|
|
2013
Q3 | – | Sell |
-30,600
| Closed | -$6.88M | – | 691 |
|
|
2013
Q2 | $6.88M | Buy |
+30,600
| New | +$6.88M | 0.02% | 251 |
|